COVID-19 Saliva Screening Test Potential Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Viral outbreaks are widespread and have caused enormous fatalities and high transmission levels. The primary component responsible for curbing the outbreaks is the 3 T's: testing, tracing, and transparency. Testing is one of the vital methods for controlling the infection spread. If an infected person is tested at the initial stage, then further transmission can be prevented. COVID-19 saliva screening tests is one of the diagnostic test used for detecting the presence of the novel coronavirus in one's body that help in isolating a patient. As the virus can be transferred via respiratory droplets, therefore, the saliva test can be used as a means for detecting coronavirus and preventing infection transmission.

MARKET SCOPE

The "Global COVID-19 Saliva Screening Test Potential Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the COVID-19 saliva screening test potential market with detailed market segmentation by location, technology, mode, and geography. The report provides key statistics on the market status of the leading COVID-19 saliva screening test potential market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

- Based on location, the global COVID-19 saliva screening test potential market is segmented into travel stations, sports arenas, entertainment venues, corporate campus environments, universities & colleges and factories.
- Based on technology, the market is segmented into fluorescence-labeled antigen/antibodies testing, RT-PCR and CRISPR-Cas9
- On the basis of mode, the market is bifurcated into centralized testing and decentralized testing.

MARKET DYNAMICS

Drivers:

- Rising demand for rapid, efficient, saliva-based screening tests and a shift toward point-of-care testing drive the COVID-19 saliva screening test potential market growth.
- Increasing investment in R&D activities for the development of simple yet effective saliva-based tests boosts the market growth.
- Increasing product approvals by regulatory bodies along with technological advancement fuel the market growth.

Restraints:

- Need of several clinical trial activities.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The COVID-19 saliva screening test potential market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the COVID-19 saliva screening test potential market in these regions.

IMPACT OF COVID-19 ON COVID-19 SALIVA SCREENING TEST POTENTIAL MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the pandemic, the worldwide economy across the various sectors has been severely impacted. However, with the reopening of different industries and locations such as public places, shopping malls, and parks, there is an increased need for screening individuals to prevent viral transmission. The increasing demand for rapid, point-of-care COVID-19 tests to mitigate viral transmission from asymptomatic people increases the market growth. Also, the at-home COVID-19 tests are gaining a considerable surge in demand as traditional testing follows the procedure of nasopharyngeal swabs, while at-home test only needs a person to spit inside a cup; after that, the sample is sent to the laboratory for testing. Thus, there is a high growth potential for the COVID-19 saliva screening test potential market with the increase in the usage of medical tests at various locations to screen individuals.

MARKET PLAYERS

The report covers key developments in the COVID-19 saliva screening test potential market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from COVID-19 saliva screening test potential market are anticipated to have lucrative growth opportunities in the future with the rising demand for COVID-19 saliva screening test potential in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the COVID-19 saliva screening test potential market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

- Ambry Genetics
- FluroTech Ltd.
- ARUP Laboratories
- Psomagen Inc.
- Vatic Health
- MOgene
- DxTerity Diagnostics, Inc.
- Fluidigm Corporation
- Abbott
- DNA Genotek, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

COVID-19 Saliva Screening Test Potential Report Scope